{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:36:49Z","timestamp":1790105809801,"version":"4.0.1"},"reference-count":43,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Given the increasing incidence of endometrial cancer (EC) and the lack of improvement in survival rates, it is imperative to explore possible prevention methods. Studies on aspirin's effect on EC risk have been controversial; research on ibuprofen remains limited. We therefore aimed to investigate the relationship between aspirin and ibuprofen use and risk of EC through a cohort study. This analysis was based on the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, which recruited participants aged 55\u201374\u2009years from 1993 to 2001, with follow\u2010up for cancer incidence continuing until December 31, 2009. A total of 42,394 women were enrolled in this analysis, and 678 cases of EC were diagnosed during a median follow\u2010up period of 12.0\u2009years. Compared with an intake of &lt;4 pills per month, the use of ibuprofen \u226530 pills per month significantly reduced EC risk (fully\u2010adjusted hazard ratio [HR], 0.75; 95% confidence interval [CI]: 0.58\u20130.98), particularly in participants with a history of cardiovascular disease (fully\u2010adjusted HR, 0.57; 95% CI: 0.37\u20130.87). No evidence was found for an association between aspirin and EC occurrence in the general population (fully\u2010adjusted HR, 0.98; 95% CI: 0.81\u20131.19), nor in specific subgroups. In conclusion, frequent ibuprofen use, unlike aspirin, was linked to reduced EC risk. This protective effect of ibuprofen was enhanced in women with a history of cardiovascular disease. Additional well\u2010designed, prospective research is needed to validate these findings and explore the underlying mechanisms.<\/jats:p>","DOI":"10.1002\/ijc.70101","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:35:29Z","timestamp":1755768929000},"page":"656-665","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association of aspirin and ibuprofen use with endometrial cancer risk in the\n                    <scp>PLCO<\/scp>\n                    dataset"],"prefix":"10.1002","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-4149","authenticated-orcid":false,"given":"Yong","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology Qilu Hospital of Shandong University  Jinan Shandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3866-3999","authenticated-orcid":false,"given":"Yuanjian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Qilu Hospital of Shandong University  Jinan Shandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Qilu Hospital of Shandong University  Jinan Shandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5419-3966","authenticated-orcid":false,"given":"Qiuyue","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Qilu Hospital of Shandong University  Jinan Shandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of International Health Johns Hopkins Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0527-6017","authenticated-orcid":false,"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical Epidemiology Unit, Qilu Hospital of Shandong University  Jinan China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingliya","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Qilu Hospital of Shandong University  Jinan Shandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaixin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Qilu Hospital of Shandong University  Jinan Shandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Qilu Hospital of Shandong University  Jinan Shandong China"},{"name":"Gynecology Oncology Key Laboratory, Qilu Hospital of Shandong University  Jinan Shandong China"},{"name":"Division of Gynecology Oncology Qilu Hospital of Shandong University  Jinan Shandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Qilu Hospital of Shandong University  Jinan Shandong China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0493"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0903"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072605"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.02.010"},{"issue":"5","key":"e_1_2_10_7_1","first-page":"1419","article-title":"Expression of cyclooxygenase\u20102 in uterine endometrial cancer and anti\u2010tumor effects of a selective COX\u20102 inhibitor","volume":"26","author":"Hasegawa K","year":"2005","journal-title":"Int J Oncol"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2002.31292"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e3181a12f91"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200103000-00019"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwp321"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0b013e32833b4871"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0390-T"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0976"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-08-0239"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-012-0117-7"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.10.005"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-08-0936"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-015-0578-4"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0457"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy541"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(00)00098-2"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(00)00097-0"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(00)00100-8"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt281"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-14-0018"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04046-0"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.10.026"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-017-9675-z"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-10-0021"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2004.tb02200.x"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/med.21514"},{"issue":"8","key":"e_1_2_10_33_1","first-page":"3150","article-title":"Ibuprofen\u2010mediated reduction of hypoxia\u2010inducible factors HIF\u20101alpha and HIF\u20102alpha in prostate cancer cells","volume":"9","author":"Palayoor ST","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.550"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20081941"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000825"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1080\/03602532.2021.1903488"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.1.47"},{"issue":"18","key":"e_1_2_10_39_1","first-page":"6096","article-title":"Breast cancer and nonsteroidal anti\u2010inflammatory drugs: prospective results from the Women's Health Initiative","volume":"63","author":"Harris RE","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv170"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105912"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60900-9"},{"key":"e_1_2_10_43_1","unstructured":"Medicines and Healthcare products Regulatory Agency.High\u2010dose Ibuprofen (\u22652400\u2009mg\/day): Small Increase in Cardiovascular Risk. 2024. Accessed July 2024.https:\/\/www.gov.uk\/drug-safety-update\/high-dose-ibuprofen-2400\u2009mg-day-small-increase-in-cardiovascular-risk"},{"key":"e_1_2_10_44_1","unstructured":"European Medicines Agency.EMA Study on Prescribing of Ibuprofen in the French Primary Care Setting. 2024. Accessed July 2024.https:\/\/catalogues.ema.europa.eu\/node\/1314\/administrative-details"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.70101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:52:52Z","timestamp":1764838372000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.70101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/ijc.70101"],"URL":"https:\/\/doi.org\/10.1002\/ijc.70101","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"2024-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}